Approved uses
The source catalogue does not contain complete approved indications. Ask for the current approved product literature and have a qualified healthcare professional confirm suitability.
Back to portfolio
Cetcort-6
A single-ingredient deflazacort tablet in the Spark pharmaceutical portfolio.
Composition at a glance
Deflazacort 6 mg
Original Spark Healthcare catalogue details.
Current specifications available from our team.
Current specifications available from our team.
SPARK / PRODUCT PORTFOLIO17
Tablet
Original catalogue artwork
Original catalogue artwork
BrandCetcort-6
Portfolio categoryPain & inflammatory care
Dosage formTablet
CompanySpark Healthcare Pvt. Ltd.
01
Product overview
A closer look.
A single-ingredient deflazacort tablet in the Spark pharmaceutical portfolio.
Cetcort-6 is presented in the pain & inflammatory care section of our portfolio. This page brings together its labelled ingredients, dosage form and original catalogue artwork, so healthcare professionals and business partners can review the available information in one place.
FormulationSingle catalogue formulation
PresentationTablet
Further informationApproved literature on request
02
Composition
Every component, clearly.
The following details are shown in the retained product artwork.
Labelled ingredient / componentSource
01Deflazacort 6 mgCatalogue label
Full excipients, serving basis, release specification and any ingredient quantities not stated in the artwork should be confirmed from the current approved pack. Different presentations of a brand are not automatically interchangeable.
03
Product label & presentation
See the original.
Review the retained catalogue artwork. Open any label at full size to inspect the source information.
Need the current pack or full specification?
Request pack sizes, approved literature, product availability and commercial information for Cetcort-6.
04
Use, storage & suitability
Information with care.
Directions for use
Follow the current label and the instructions given by your healthcare professional. A labelled ingredient strength is not a recommended daily dose.
Precautions & interactions
Ask your doctor or pharmacist to review allergies, other medicines, supplements, pregnancy or breastfeeding, and relevant medical conditions before use.
Storage & handling
Follow the storage conditions on the current pack, including any temperature or light restrictions. Check the expiry date and keep products away from children.
05
Product questions
A few helpful answers.
What is Cetcort-6?+
A single-ingredient deflazacort tablet in the Spark pharmaceutical portfolio.
What does Cetcort-6 contain?+
Deflazacort 6 mg. These details are transcribed from the supplied catalogue artwork. Check the current approved label for the complete formula and excipients.
How should this product be used?+
The amount, frequency and duration should come from the current approved label and your healthcare professional. The strengths shown on this page describe the product; they are not dosing instructions.
How can I confirm pack size, price and availability?+
Send a product enquiry mentioning Cetcort-6. Our team can confirm the current pack, availability, commercial terms and approved product literature.
Can I discuss distribution or franchise supply?+
Yes. Share your city, state and business requirements in a partnership enquiry. Territory availability and commercial terms are confirmed by the Spark Healthcare team.
Let’s take the next step
More clarity.
A better conversation.
Talk to us about Cetcort-6, current specifications or a potential partnership.
Enquire about Cetcort-6Continue exploring
More from
the Spark portfolio.
Pain & inflammatory care
Trypcare Plus
Trypsin BP 48 mg + Bromelain 90 mg + Rutoside trihydrate BP 100 mg
TabletView details
Bone & mineral care
Calirit D3 (Nano Shot)
Vitamin D3 60,000 IU
Oral solutionView details
Personal care
Easy Wash
Vaginal antiseptic solution — individual ingredients not stated
External solutionView details